Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-01-05 @ 11:44 PM
Study NCT ID:
NCT03726333
Status:
TERMINATED
Last Update Posted:
2024-06-21
First Post:
2018-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Hepatic Impairment Study for Lorlatinib in Cancer Patients
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
B7461009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None